Managed by Atlas Venture Life Science Advisors, Llc • Latest filing Q4 2025
Overlap peers will appear here as data populates
Related fund suggestions coming soon.
| $231.7M |
| 4.90M |
| 0.00% |
| — |
| 6 | D DYN — | $227.7M | 8.02M | 0.00% | — |
| 7 | L LZB — | $216.2M | 5.38M | 0.00% | — |
| 8 | L LZB — | $213.7M | 4.90M | 0.00% | — |
| 9 | L LZB — | $197M | 4.90M | 0.00% | — |
| 10 | D DYN — | $188.9M | 8.02M | 0.00% | — |
| 11 | D DYN — | $178.6M | 9.13M | 0.00% | — |
| 12 | L LZB — | $173.6M | 5.86M | 0.00% | — |
| 13 | L LZB — | $159.7M | 5.35M | 0.00% | — |
| 14 | I IRON — | $159.1M | 2.51M | 0.00% | — |
| 15 | I IRON — | $153.7M | 3.46M | 0.00% | — |
| 16 | L LZB — | $149.2M | 5.86M | 0.00% | — |
| 17 | ? N/A — | $147.8M | 10.91M | 0.00% | — |
| 18 | I IRON — | $147.6M | 2.56M | 0.00% | — |
| 19 | I IRON — | $142.4M | 2.29M | 0.00% | — |
| 20 | ? N/A — | $141.8M | 10.91M | 0.00% | — |